Gandhi, M.; Chela, H.K.; Barffour, M.A.; Bosak, E.; Reznicek, E.; Luton, K.; Bechtold, M.; Ghouri, Y.A.
Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease. Biologics 2025, 5, 38.
https://doi.org/10.3390/biologics5040038
AMA Style
Gandhi M, Chela HK, Barffour MA, Bosak E, Reznicek E, Luton K, Bechtold M, Ghouri YA.
Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease. Biologics. 2025; 5(4):38.
https://doi.org/10.3390/biologics5040038
Chicago/Turabian Style
Gandhi, Mustafa, Harleen Kaur Chela, Maxwell A. Barffour, Emily Bosak, Emily Reznicek, Kevin Luton, Matthew Bechtold, and Yezaz A. Ghouri.
2025. "Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease" Biologics 5, no. 4: 38.
https://doi.org/10.3390/biologics5040038
APA Style
Gandhi, M., Chela, H. K., Barffour, M. A., Bosak, E., Reznicek, E., Luton, K., Bechtold, M., & Ghouri, Y. A.
(2025). Risk of Developing Clostridioides Difficile Infection with the Use of Proton Pump Inhibitors in Patients with Inflammatory Bowel Disease. Biologics, 5(4), 38.
https://doi.org/10.3390/biologics5040038
